Toby Richards/LinkedIn
Aug 21, 2026, 21:58
Toby Richards: WEHI Trial Solidifies IV Iron as Third-Trimester Standard
Toby Richards, Director of The Iron Clinic, Professor of Surgery at University College London, shared a post on LinkedIn:
“Very Important trial from WEHI (Walter and Eliza Hall Institute of Medical Research) looking at Anaemia in Pregnancy, this is now the second RCT showing IV iron is the preferred choice in the last trimester.
Iron deficiency remains a WHO top 5 cause of disability and disproportionately impacts women of reproductive ability. It ranks higher than having diabetes! Yet it is easy to treat with a 15-30 IV iron infusion.”
Stay updated with Hemostasis Today.
-
Oct 12, 2026, 17:15Cedric Hermans: Identifying and Diagnosing Hemophilia Carriers and Affected Females
-
Oct 12, 2026, 17:01Bianca Rocca: Evaluating Factor XI Inhibition Lessons from LIBREXIA-ACS
-
Oct 12, 2026, 13:58Francisco Chacón-Lozsán: Catastrophic Antiphospholipid Syndrome A Rapidly Progressive Multiorgan Thrombotic Emergency
-
Oct 12, 2026, 12:50Nawsherwan Mohammad: Study Examines Thrombotic Events in Patients with Polycythemia Vera in Iraq
-
Oct 12, 2026, 12:30Chanakya Nayudu: Looking Beyond Blood Clots – Patient-Reported Outcomes in Antiphospholipid Syndrome
-
Oct 12, 2026, 12:12Jean-Jacques Kiladjian: Improving Treatment Strategies with JAK Inhibitors in Myelofibrosis
-
Oct 12, 2026, 12:04Chloe Homich: AABB Annual Meetings – Building Connections and Advancing Transfusion Medicine
-
Oct 12, 2026, 11:51Daniel Sop: Sickle Cell Research Takes Center Stage at ASCAT 2026
-
Oct 12, 2026, 10:36PAI-1 Inhibition as a New Strategy for Enhancing Fibrinolysis and Clot Resolution